Publication Name	World Journal of Transplantation
Manuscript ID	96696
Country	Taiwan

Received	2024-08-14 02:42
Peer-Review Started	2024-05-14 03:34
To Make the First Decision
Return for Revision	2024-09-19 22:03
Revised	2024-10-02 01:35
Second Decision	2024-10-14 02:40
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-10-15 00:34
Articles in Press	2024-10-15 00:34
Publication Fee Transferred	2024-10-15 07:49
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-10-31 03:09
Publish the Manuscript Online	2024-11-27 08:57

ISSN	2220-3230 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: Https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Transplantation
Manuscript Type	Case Report
Article Title	Success of intravenous immunoglobulin and steroids in managing severe COVID-19 following lung transplantation: A case report
Manuscript Source	Unsolicited Manuscript
All Author List	Yen-Shou Kuo, Kuan-Hsun Lin, Ying-Yi Chen, Yuan-Ming Tsai, Ti-Hui Wu, Hsu-Kai Huang and Tsai-Wang Huang
Funding Agency and Grant Number
Corresponding Author	Tsai-Wang Huang, MD, PhD, Professor, Surgeon, Surgical Oncologist, Division of Thoracic Surgery, Department of Surgery, Tri-Service General Hospital, National Defense Medical Center, No. 325 Section 2, Chenggong Rd, Neihu District, Taipei 114202, Taiwan. chi-wang@yahoo.com.tw
Key Words	COVID-19; Septic shock; Intravenous immunoglobulin; Lung transplantation; Post-transplant complications; Case report
Core Tip	The first successful experience indicated intravenous immunoglobulin as a valuable adjunct in managing severe coronavirus disease 2019 infection complicated with severe acute respiratory distress syndrome and septic shock in a lung transplant recipient.
Publish Date	2024-11-27 08:57
Citation	<p>Kuo YS, Lin KH, Chen YY, Tsai YM, Wu TH, Huang HK, Huang TW. Success of intravenous immunoglobulin and steroids in managing severe COVID-19 following lung transplantation: A case report. <i>World J Transplant</i> 2025; 15(1): 96696</p>
URL	https://www.wjgnet.com/2220-3230/full/v15/i1/96696.htm
DOI	https://dx.doi.org/10.5500/wjt.v15.i1.96696

Full Article (PDF)	WJT-15-96696-with-cover.pdf
CARE Checklist–2016	96696-CARE-Checklist-2016.pdf
Manuscript File	96696_Auto_Edited_033420.docx
Answering Reviewers	96696-answering-reviewers.pdf
Audio Core Tip	96696-audio.m4a
Conflict-of-Interest Disclosure Form	96696-conflict-of-interest-statement.pdf
Copyright License Agreement	96696-copyright-assignment.pdf
Signed Consent for Treatment Form(s) or Document(s)	96696-informed-consent-statement.pdf
Non-Native Speakers of English Editing Certificate	96696-non-native-speakers.pdf
Peer-review Report	96696-peer-reviews.pdf
Scientific Editor Work List	96696-scientific-editor-work-list.pdf
CrossCheck Report	96696-crosscheck-report.pdf